Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints

Alexandra Erdmann, Jan Beyersmann, Kaspar Rufibach

When planning an oncology clinical trial, the usual approach is to assume proportional hazards and even an exponential distribution for time-to-event endpoints. Often, besides the…